WASHINGTON, DC — NORML staffers on Wednesday hand-delivered over 10,000 public comments to the US Food and Drug Administration calling on the agency to recommend amending the substance’s illicit status under international treaties.
The agency had requested public comments so that they could be “considered in preparing a response from the United States to the World Health Organization regarding the abuse liability and diversion” of marijuana and certain other substances.
It is the second time this year the FDA has sought the public’s feedback with regard to cannabis scheduling. In April, NORML staffers also delivered over 10,000 written comments to the agency from members of the public.
Writing to the FDA on NORML’s behalf, Deputy Director Paul Armentano opined “that cannabis be removed from the international drug conventions so that nations that wish to do so may further expand their regulations governing cannabis’ use, possession, production, and dispensing for either recreational or medical use.”